Global Metabolomics Market to Witness 13% CAGR until 2025

According to the latest report by IMARC Group titled, “Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the market to grow at a CAGR of around 13% during 2020-2025.

Metabolomics refers to the study of metabolites, small molecule substrates, intermediates and products of metabolism. It is used for phenotyping of genetically modified plants, identifying gene function and analyzing biotic-abiotic stress reaction. It helps researchers and scientists in calculating the physiological effects and metabolism of drugs. At present, the demand for metabolomics is escalating as it offers an assessment of health as well as causes and treatment of different medical ailments.

Market Trends

The thriving healthcare industry is one of the key factors driving the market growth. In line with this, metabolomics is extensively employed in the healthcare industry for the discovery and optimization of a lead compound and identification of biomarkers, which is contributing to the market growth significantly. Apart from this, the increasing demand for personalized medicines and technological advancements in analytical techniques is further bolstering the market growth. Other factors, such as the growing geriatric population and rising investments by governments of several countries on healthcare infrastructure, are expected to drive the market in the upcoming years.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Metabolomics Market 2020-2025 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

The report has segmented the market on the basis of Product, Indication, Application and Region.

Market Breakup by Product:

Metabolomics Instruments
Metabolomics Bioinformatics Tools and Services

Market Breakup by Indication:

Cancer
Cardiovascular Disorders
Neurological Disorders
Inborn Errors of Metabolism
Others

Market Breakup by Application:

Biomarker and Drug Discovery
Toxicology
Nutrigenomics
Personalized Medicine
Others

Market Breakup by Region:

North America
Asia Pacific
Europe
United Kingdom
Latin America
Middle East and Africa

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: [email protected]
Follow us on twitter: @imarcglobal

Author's Note

For more info, click here: https://www.imarcgroup.com/metabolomics-market